Accuracy of predicting axillary lymph node positivity by physical examination, mammography, ultrasonography, and magnetic resonance imaging
- PMID: 22227922
- DOI: 10.1245/s10434-011-2200-7
Accuracy of predicting axillary lymph node positivity by physical examination, mammography, ultrasonography, and magnetic resonance imaging
Abstract
Background: Axillary lymph node status continues to be among the most important prognostic variables regarding breast cancer survival. We were interested in our ability to accurately predict axillary nodal involvement by using physical examination and standard breast imaging studies in combination.
Methods: A retrospective review was performed of 244 consecutive patients diagnosed with invasive breast carcinoma between May 2008 and December 2010 who underwent physical examination of the axilla, digital mammography, axillary ultrasonography, and contrast-enhanced breast magnetic resonance imaging and who had subsequent histopathologic evaluation of one or more axillary lymph nodes.
Results: A total of 62 (25%) of 244 women were found to have positive axillary lymph nodes on final histopathologic examination, 42% of whom were able to be identified preoperatively. The sensitivity for predicting axillary metastasis if any one or more examination modalities were suspicious was 56.5%. The specificity for predicting axillary metastasis if any three or more modalities were suspicious was 100%. Of the patients who had all four modalities negative, 14% were ultimately found to have histologically positive nodes at the time of surgery.
Conclusions: Physical examination and multimodal imaging in combination are useful for preoperative axillary staging and treatment planning. However, they remain inadequate definitive predictors of axillary lymph node involvement.
Similar articles
-
Preoperative axillary ultrasound and fine-needle aspiration biopsy in the diagnosis of axillary metastases in patients with breast cancer: predictors of accuracy and future implications.Ann Surg Oncol. 2013 Mar;20(3):819-27. doi: 10.1245/s10434-012-2609-7. Epub 2012 Sep 13. Ann Surg Oncol. 2013. PMID: 22972506
-
Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.J Surg Oncol. 2004 Mar;85(3):102-11. doi: 10.1002/jso.20022. J Surg Oncol. 2004. PMID: 14991881 Review.
-
Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer.Ann Surg Oncol. 2009 Dec;16(12):3388-95. doi: 10.1245/s10434-009-0653-8. Ann Surg Oncol. 2009. PMID: 19655200 Clinical Trial.
-
Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology.Ann Surg Oncol. 2007 Oct;14(10):2928-31. doi: 10.1245/s10434-007-9452-2. Epub 2007 Aug 1. Ann Surg Oncol. 2007. PMID: 17674108
-
[Management of the axilla in breast cancer: evidences and unresolved issues].Orv Hetil. 2001 Sep 9;142(36):1941-50. Orv Hetil. 2001. PMID: 11680099 Review. Hungarian.
Cited by
-
Utilizing multiclassifier radiomics analysis of ultrasound to predict high axillary lymph node tumour burden in node-positive breast cancer patients: a multicentre study.Ann Med. 2024 Dec;56(1):2395061. doi: 10.1080/07853890.2024.2395061. Epub 2024 Aug 28. Ann Med. 2024. PMID: 39193658 Free PMC article.
-
Utility of Ultrasound and Mammography in Detection of Negative Axillary Nodal Metastasis in Breast Cancer.Cureus. 2020 Jan 17;12(1):e6691. doi: 10.7759/cureus.6691. Cureus. 2020. PMID: 32104628 Free PMC article.
-
The combination of contrast-enhanced ultrasonography with blue dye for sentinel lymph node detection in clinically negative node breast cancer.Arch Gynecol Obstet. 2021 Dec;304(6):1551-1559. doi: 10.1007/s00404-021-06021-x. Epub 2021 Jul 9. Arch Gynecol Obstet. 2021. PMID: 34241688 Clinical Trial.
-
The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07).BMC Cancer. 2015 Sep 3;15:610. doi: 10.1186/s12885-015-1613-2. BMC Cancer. 2015. PMID: 26335105 Free PMC article. Clinical Trial.
-
Ultrasound Imaging Technologies for Breast Cancer Detection and Management: A Review.Ultrasound Med Biol. 2018 Jan;44(1):37-70. doi: 10.1016/j.ultrasmedbio.2017.09.012. Epub 2017 Oct 26. Ultrasound Med Biol. 2018. PMID: 29107353 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical